Aeluma (NASDAQ:ALMU) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Aeluma (NASDAQ:ALMU) announced its earnings results on Wednesday. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.01, FiscalAI reports. The company had revenue of $1.22 million during the quarter, compared to the consensus estimate of $1.37 million. Aeluma had a negative return on equity of 8.15% and a negative net margin of 52.48%.

Here are the key takeaways from Aeluma’s conference call:

• Aeluma said customer interest accelerated after OFC, especially in AI datacom, where supply constraints around lasers and indium phosphide substrates are creating near-term opportunities for its non-indium phosphide photonics.
• The company highlighted its high-speed InGaAs photodiodes and quantum dot lasers as key products, arguing they can help customers overcome performance, power, reliability, and packaging bottlenecks in data center applications.
• Aeluma reported it has secured 6 government development contracts this fiscal year, exceeding its goal of 3 to 7 and bringing in more than $5 million in non-dilutive funding.
• Fiscal third-quarter revenue was $1.2 million, while GAAP net loss was $1.8 million and non-GAAP net loss was $701,000. The company ended the quarter with $37.8 million in cash and no long-term debt.
• Aeluma narrowed full-year revenue guidance to $4.2 million to $4.6 million from $4 million to $6 million, citing delays in government contract execution and shutdown-related timing shifts.

Aeluma Price Performance

NASDAQ ALMU traded down $4.84 on Thursday, hitting $26.65. 5,215,354 shares of the stock were exchanged, compared to its average volume of 1,101,127. Aeluma has a 52-week low of $10.20 and a 52-week high of $31.79. The company has a market capitalization of $479.78 million, a price-to-earnings ratio of -190.34 and a beta of 4.49. The company’s 50-day moving average price is $16.94 and its two-hundred day moving average price is $16.54.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. Williams Trading set a $25.00 target price on Aeluma in a research note on Tuesday, March 3rd. Weiss Ratings restated a “sell (d-)” rating on shares of Aeluma in a research note on Monday, April 20th. UBS Group reiterated a “buy” rating on shares of Aeluma in a research report on Tuesday, March 3rd. Freedom Capital upgraded Aeluma to a “strong-buy” rating in a research report on Tuesday, March 31st. Finally, Benchmark reissued a “buy” rating and set a $25.00 target price on shares of Aeluma in a report on Tuesday, March 3rd. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $25.33.

Insider Buying and Selling at Aeluma

In other Aeluma news, CEO Jonathan Klamkin sold 50,000 shares of the firm’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $18.05, for a total transaction of $902,500.00. Following the transaction, the chief executive officer directly owned 1,429,398 shares in the company, valued at $25,800,633.90. This trade represents a 3.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Steven Denbaars sold 12,500 shares of the firm’s stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $17.58, for a total value of $219,750.00. Following the transaction, the director owned 397,588 shares in the company, valued at approximately $6,989,597.04. This trade represents a 3.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 102,500 shares of company stock worth $1,883,450. 14.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. &PARTNERS raised its position in shares of Aeluma by 6.5% during the fourth quarter. &PARTNERS now owns 15,057 shares of the company’s stock valued at $259,000 after buying an additional 923 shares during the last quarter. Goldman Sachs Group Inc. bought a new stake in Aeluma in the fourth quarter valued at about $230,000. Bank of America Corp DE bought a new stake in Aeluma during the second quarter worth about $98,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Aeluma during the second quarter worth about $86,000. Finally, New York State Common Retirement Fund bought a new stake in Aeluma during the second quarter worth about $111,000.

About Aeluma

Aeluma, Inc develops optoelectronic and electronic devices in the United States. The company manufactures semiconductor materials and chips using compound semiconductors on diameter substrates that are used to manufacture mass market microelectronics. It offers its devices for use in mobile, automotive, AI, defence and aerospace, communication, AR/VR, and HPC applications, as well as laser emitters, transistors for integrated circuits, quantum photonic circuits, and solar cells applications. Aeluma, Inc was formerly known as Parc Investments, Inc and changed its name to Aeluma, Inc June 2021.